MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 8, Issue 2, Pages e2603-e2603
Publisher
Springer Nature
Online
2017-02-09
DOI
10.1038/cddis.2016.352
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Suppression of Reserve MCM Complexes Chemosensitizes to Gemcitabine and 5-Fluorouracil
- (2015) V. L. Bryant et al. MOLECULAR CANCER RESEARCH
- Extremely Low-Frequency Electromagnetic Fields Affect the miRNA-Mediated Regulation of Signaling Pathways in the GC-2 Cell Line
- (2015) Yong Liu et al. PLoS One
- Histone deacetylase inhibitor SAHA epigenetically regulates miR-17-92 cluster and MCM7 to upregulate MICA expression in hepatoma
- (2014) H Yang et al. BRITISH JOURNAL OF CANCER
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hepatocellular carcinoma: clinical frontiers and perspectives
- (2014) Jordi Bruix et al. GUT
- MAPK signaling mediates sinomenine hydrochloride-induced human breast cancer cell death via both reactive oxygen species-dependent and -independent pathways: an in vitro and in vivo study
- (2014) X Li et al. Cell Death & Disease
- Negative regulation of transcription factor FoxM1 by p53 enhances oxaliplatin-induced senescence in hepatocellular carcinoma
- (2012) Kai Qu et al. CANCER LETTERS
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2012) EUROPEAN JOURNAL OF CANCER
- MCM7 expression predicts post-operative prognosis for hepatocellular carcinoma
- (2012) Yan-Ming Zhou et al. LIVER INTERNATIONAL
- Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC)
- (2012) Yi-Zhen Liu et al. LUNG CANCER
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Minichromosome Maintenance Protein 7 is a potential therapeutic target in human cancer and a novel prognostic marker of non-small cell lung cancer
- (2011) Gouji Toyokawa et al. Molecular Cancer
- ATX-LPA receptor axis in inflammation and cancer
- (2010) Shuying Liu et al. CELL CYCLE
- The changing pattern of epidemiology in hepatocellular carcinoma
- (2010) Helena Nordenstedt et al. DIGESTIVE AND LIVER DISEASE
- Minichromosome maintenance protein 7 as a potential prognostic factor for progression-free survival in high-grade serous carcinomas of the ovary
- (2010) Takayo Ota et al. MODERN PATHOLOGY
- Reducing MCM levels in human primary T cells during the G0→G1 transition causes genomic instability during the first cell cycle
- (2010) S J Orr et al. ONCOGENE
- Minichromosome maintenance proteins 2, 3 and 7 in medulloblastoma: overexpression and involvement in regulation of cell migration and invasion
- (2010) K-M Lau et al. ONCOGENE
- Mitogen-activated protein kinases in hepatocellular carcinoma development
- (2010) Lihua Min et al. SEMINARS IN CANCER BIOLOGY
- The miR-106b-25 Polycistron, Activated by Genomic Amplification, Functions as an Oncogene by Suppressing p21 and Bim
- (2009) Takatsugu Kan et al. GASTROENTEROLOGY
- Expression of minichromosome maintenance 7 (MCM7) in small lung adenocarcinomas (pT1): Prognostic implication
- (2009) Shinji Fujioka et al. LUNG CANCER
- Excess MCM proteins protect human cells from replicative stress by licensing backup origins of replication
- (2008) Arkaitz Ibarra et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started